What’s next for Pfizer’s COVID-19 vaccine after UK rollout,

– Pfizer signed a deal worth up to $750 million with BioNTech in March to co-develop the potential vaccine, and it ran clinical trials in April. – Testing of …, – Pfizer signed a deal worth up to $750 million with BioNTech in March to co-develop the potential vaccine, and it ran clinical trials in April. – Testing of …, Read More

Scroll to Top